This resource supports the use of Glycosade® in the dietary management of children and adults with hepatic glycogen storage disease where the use of a long acting starch is indicated.
Weinstein Rare Disease and Clinical Development Consulting, USA
Dr. Ulrike Steuerwald MPH
Consultant for Inborn Errors occurring in the Faroe Islands, Medical Center and Senior Research Associate, Department of Research, National Hospital of the Faroe Islands
